This article is a correction to:
The role of peroxisome proliferator-activated receptors in the modulation of hyperinflammation induced by SARS-CoV-2 infection: A perspective for COVID-19 therapy
Aliakbar Hasankhani1*†
Abolfazl Bahrami1,2†
Bahareh Tavakoli-Far3,4Setare Iranshahi5Farnaz Ghaemi6Majid Reza Akbarizadeh7Ali H. Amin8Bahman Abedi Kiasari9*Alireza Mohammadzadeh Shabestari10,11*- 1Department of Animal Science, College of Agriculture and Natural Resources, University of Tehran, Karaj, Iran
- 2Faculty of Agricultural Sciences and Engineering, University of Tehran, Karaj, Iran
- 3Dietary Supplements and Probiotic Research Center, Alborz University of Medical Sciences, Karaj, Iran
- 4Department of Physiology and Pharmacology, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran
- 5School of Pharmacy, Shahid Beheshty University of Medical Sciences, Tehran, Iran
- 6Department of Biochemistry, Faculty of Advanced Sciences and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran
- 7Department of Pediatric, School of Medicine, Amir al momenin Hospital, Zabol University of Medical Sciences, Zabol, Iran
- 8Zoology Department, Faculty of Science, Mansoura University, Mansoura, Egypt
- 9Virology Department, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran
- 10Department of Dental Surgery, Mashhad University of Medical Sciences, Mashhad, Iran
- 11Khorasan Covid-19 Scientific Committee, Mashhad, Iran
By Hasankhani A, Bahrami A, Tavakoli-Far B, Iranshahi S, Ghaemi F, Akbarizadeh MR, Amin AH, Abedi Kiasari B and Mohammadzadeh Shabestari A (2023). Front. Immunol. 14:1127358. doi: .10.3389/fimmu.2023.1127358
Incorrect Affiliation
In the published article, there was an error in affiliation 2. Instead of “Biomedical Center for Systems Biology Science Munich, Ludwig-Maximilians-University, Munich, Germany”, it should be “Faculty of Agricultural Sciences and Engineering, University of Tehran, Karaj, Iran”.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: SARS-CoV-2, cytokine storm, PPARs, hyperinflammation, COVID-19 therapy
Citation: Hasankhani A, Bahrami A, Tavakoli-Far B, Iranshahi S, Ghaemi F, Akbarizadeh MR, Amin AH, Abedi Kiasari B and Mohammadzadeh Shabestari A (2024) Corrigendum: The role of peroxisome proliferator-activated receptors in the modulation of hyperinflammation induced by SARS-CoV-2 infection: A perspective for COVID-19 therapy. Front. Immunol. 15:1422261. doi: 10.3389/fimmu.2024.1422261
Received: 23 April 2024; Accepted: 24 April 2024;
Published: 08 May 2024.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2024 Hasankhani, Bahrami, Tavakoli-Far, Iranshahi, Ghaemi, Akbarizadeh, Amin, Abedi Kiasari and Mohammadzadeh Shabestari. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Aliakbar Hasankhani, A.hasankhani74@ut.ac.ir; Bahman Abedi Kiasari, abedikiasari.b@ut.ac.ir; Alireza Mohammadzadeh Shabestari, Drshabestari3@gmail.com
†These authors have contributed equally to this work and share first authorship